Systems biological and mechanistic modelling of radiation-induced cancer

Radiation and Environmental Biophysics

Volumn 47, Issue 1, 2008, Pages 39-47

  Little, M P ^a   Heidenreich, W F ^b   Moolgavkar, S H ^c   Schollnberger H ^d   Thomas, D C ^e  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c Fred Hutchinson Cancer Research Center   (United States)

^d UNIVERSITY OF SALZBURG   (Austria)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MULTISTAGE CARCINOGENESIS; NEOPLASTIC TRANSFORMATION;

BIOACTIVITY; CARCINOGENS; CELL CULTURE; DNA SEQUENCES; RADIATION EFFECTS; RADIOTHERAPY;

TUMORS;

BREAST CANCER; CANCER INCIDENCE; CANCER RISK; CHROMOSOME ABERRATION; CONFERENCE PAPER; DOUBLE STRANDED DNA BREAK; HUMAN; RADIATION CARCINOGENESIS; RADIATION INJURY; SYSTEMS BIOLOGY;

ANIMALS; CELL COMMUNICATION; CELL TRANSFORMATION, NEOPLASTIC; DNA DAMAGE; DNA REPAIR; HUMANS; MODELS, BIOLOGICAL; NEOPLASMS, RADIATION-INDUCED; RADIATION, IONIZING; SIGNAL TRANSDUCTION; STOCHASTIC PROCESSES; SYSTEMS BIOLOGY;

EID: 39049102503     PISSN: 0301634X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00411-007-0150-z     Document Type: Conference Paper

References (66)

1. Moolgavkar SH, Venzon DJ (1979) Two-event model for carcinogenesis: incidence curves for childhood and adult tumors. Math Biosci 47:55-77
2. Moolgavkar SH, Knudson AG (1981) Mutation and cancer: a model for human carcinogenesis. J Natl Cancer Inst 66:1037-1052
3. Frank SA, Nowak MA (2003) Developmental predisposition to cancer. Nature 422:494
4. Meza R, Luebeck EG, Moolgavkar SH (2005) Gestational mutations and carcinogenesis. Math Biosci 197:188-210
5. Luebeck EG, Moolgavkar SH (2002) Multistage carcinogenesis and the incidence of colorectal cancer. Proc Natl Acad Sci USA 99:15095-15100
6. Moolgavkar SH, Luebeck EG, Krewski D, Zielinski JM (1993) Radon, cigarette smoke, and lung cancer: a reanalysis of the Colorado Plateau uranium miners' data. Epidemiology 4:204-217
7. Luebeck EG, Curtis SB, Cross FT, Moolgavkar SH (1996) Two-stage model of radon-induced malignant lung tumors in rats: effects of cell killing. Radiat Res 145:163-173
8. Hazelton WD, Moolgavkar SH, Curtis SB, Zielinski JM, Ashmore JP, Krewski D (2006) Biologically based analysis of lung cancer incidence in a large Canadian occupational cohort with low-dose ionizing radiation exposure, and comparison with Japanese atomic bomb survivors. J Toxicol Environ Health 69:1013-1038
9. Dewanji A, Venzon DJ, Moolgavkar SH (1989) A stochastic two-stage model for cancer risk assessment II: the number and size of premalignant clones. Risk Anal 9:179-186
10. Jeon J, Meza R, Moolgavkar SH, Luebeck EG (2007) Analyses of intermediate lesions in multistage carcinogenesis. Math Biosci (submitted)
11. Moolgavkar SH, Luebeck EG, de Gunst M, Port RE, Schwarz M (1990) Quantitative analysis of enzyme-altered foci in rat hepatocarcinogenesis experiments-I. Single agent regimen. Carcinogenesis 11:1271-1278
12. Moolgavkar SH, Luebeck EG, Buchmann A, Bock KW (1996) Quantitative analysis of enzyme-altered foci in rats initiated with diethylnitrosamine and promoted with 2,3,7,8-tetrachlorodibenzo-p-dioxin or 1,2,3,4,6,7,8- heptachlorodibenzo-p-dioxin. Toxicol Appl Pharmacol 138:31-42
13. Gatenby RA, Maini PK (2003) Cancer summed up. Nature 421:321
14. National Research Council, Committee to assess health risks from exposure to low levels of ionizing radiation (2006) Health risks from exposure to low levels of ionizing radiation. BEIR VII Phase 2. National Academy Press, Washington DC
15. Heidenreich WF, Jacob P, Paretzke HG (1997) Exact solutions of the clonal expansion model and their application to the incidence of solid tumors of atomic bomb survivors. Radiat Environ Biophys 36:45-58
16. Heidenreich WF, Luebeck EG, Hazelton WD, Paretzke HG, Moolgavkar SH (2002) Multistage models and the incidence of cancer in the cohort of atomic bomb survivors. Radiat Res 158:607-614
17. Heidenreich WF (2002) Signals for a promoting action of radiation in cancer incidence data. J Radiol Prot 22:A71-A74
18. Heidenreich WF, Carnes BA, Paretzke HG (2006) Lung cancer risk in mice: analysis of fractionation effects and neutron RBE with a biologically motivated model. Radiat Res 166:794-801
19. Kaiser JC, Heidenreich WF, Monchaux G, Morlier JP, Collier CG (2004) Lung tumour risk in radon-exposed rats from different experiments: comparative analysis with biologically based models. Radiat Environ Biophys 43:189-201
20. Heidenreich WF, Tomášek L, Rogel A, Laurier D, Tirmarche M (2004) Studies of radon-exposed miner cohorts using a biologically based model: comparison of current Czech and French data with historic data from China and Colorado. Radiat Environ Biophys 43:247-256
21. Luebeck EG, Heidenreich WF, Hazelton WD, Paretzke HG, Moolgavkar SH (1999) Biologically based analysis of the data for the Colorado uranium miners cohort: age, dose and dose-rate effects. Radiat Res 152:339-351
22. Heidenreich WF, Nyberg U, Hall P (2003) A biologically based model for liver cancer risk in the Swedish Thorotrast patients. Radiat Res 159:656-662
23. 224Ra: protraction effects from promotion. Radiat Environ Biophys 44:61-67
24. Heidenreich WF, Jacob P, Paretzke HG, Cross FT, Dagle GE (1999) Two-step model for the risk of fatal and incidental lung tumors in rats exposed to radon. Radiat Res 151:209-217
25. Heidenreich WF, Atkinson M, Paretzke HG (2001) Radiation-induced cell inactivation can increase the cancer risk. Radiat Res 155:870-872
26. Heidenreich WF (2005) Heterogeneity of cancer risk due to stochastic effects. Risk Anal 25:1589-1594
27. Heidenreich WF (2006) Heterogeneity of cancer risk due to stochastic effects: emphasis on radiation-induced effects. Radiat Environ Biophys 45:33-37
28. RISC-RAD (2007) http://www.riscrad.org
29. Morgan WF (2003) Non-targeted and delayed effects of exposure to ionizing radiation: I. Radiation-induced genomic instability and bystander effects in vitro. Radiat Res 159:567-580
30. Morgan WF (2003) Non-targeted and delayed effects of exposure to ionizing radiation: II. Radiation-induced genomic instability and bystander effects in vivo, clastogenic factors and transgenerational effects. Radiat Res 159:581-596
31. Loeb LA (1991) Mutator phenotype may be required for multistage carcinogenesis. Cancer Res 51:3075-3079
32. Loeb LA (2001) A mutator phenotype in cancer. Cancer Res 61:3230-3239
33. Stoler DL, Chen N, Basik M, Kahlenberg MS, Rodriguez-Bigas MA, Petrelli NJ, Anderson GR (1999) The onset and extent of genomic instability in sporadic colorectal tumor progression. Proc Natl Acad Sci USA 96:15121-15126
34. Tomlinson I, Bodmer W (1999) Selection, the mutation rate and cancer: ensuring that the tail does not wag the dog. Nature Med 5:11-12
35. Nowak MA, Komarova NL, Sengupta A, Jallepalli PV, Shih I-M, Vogelstein B, Lengauer C (2002) The role of chromosomal instability in tumor initiation. Proc Natl Acad Sci USA 99:16226-16231
36. Little MP, Wright EG (2003) A stochastic carcinogenesis model incorporating genomic instability fitted to colon cancer data. Math Biosci 183:111-134
37. Knudson AG Jr (1971) Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 68:820-823
38. Little MP (1995) Are two mutations sufficient to cause cancer? Some generalizations of the two-mutation model of carcinogenesis of Moolgavkar, Venzon, and Knudson, and of the multistage model of Armitage and Doll. Biometrics 51:1278-1291
39. Mao JH, Lindsay KA, Balmain A, Wheldon TE (1998) Stochastic modelling of tumorigenesis in p53 deficient mice. Br J Cancer 77:243-252
40. Little MP, Li G (2007) Stochastic modelling of colon cancer: is there a role for genomic instability? Carcinogenesis 28:479-487
41. Surveillance Epidemiology and End Results (SEER) Registry public-use data, 1973-2002 (2005) Cancer Statistics Branch, Surveillance Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda ( http://www.seer.cancer.gov/ )
42. Jackson AL, Loeb LA (1998) On the origin of multiple mutations in human cancers. Semin Cancer Biol 8:421-429
43. Degnen GE, Cox EC (1974) Conditional mutator gene in Escherichia coli: isolation, mapping, and effector studies. J Bacteriol 117:477-487
44. Lancy ED, Lifsics MR, Kehres DG, Maurer R (1989) Isolation and characterization of mutants with deletions in dnaQ, the gene for the editing subunit of DNA polymerase III in Salmonella typhimurium. J Bacteriol 171:5572-5580
45. Redpath JL, Liang D, Taylor TH, Christie C, Elmore E (2001) The shape of the dose-response curve for radiation-induced neoplastic transformation in vitro: evidence for an adaptive response against neoplastic transformation at low doses of low-LET radiation. Radiat Res 156:700-707
46. Fleishman L, Crawford-Brown DJ, Hofmann W (2007) A computational model for radiation-induced cellular transformation to in vitro irradiation of cells by acute doses of X-rays. Math Biosci (submitted)
47. Portess DI, Bauer G, Hill MA, O'Neill P (2007) Low-dose irradiation of nontransformed cells stimulates the selective removal of precancerous cells via intercellular induction of apoptosis. Cancer Res 67:1246-1253
48. Azzam EI, de Toledo SM, Raaphorst GP, Mitchel REJ (1996) Low-dose ionizing radiation decreases the frequency of neoplastic transformation to a level below the spontaneous rate in C3H 10T1/2 cells. Radiat Res 146:369-373
49. Redpath JL, Antoniono RJ (1998) Induction of an adaptive response against spontaneous neoplastic transformation in vitro by low-dose gamma radiation. Radiat Res 149:517-520
50. Schöllnberger H, Eckl PM (2007) Protective bystander effects simulated with the State-Vector Model. Dose-Response 5:187-203
51. Schöllnberger H, Mitchel REJ, Redpath JL, Crawford-Brown DJ, Hofmann W (2007) Detrimental and protective bystander effects: a model approach. Radiat Res 168:614-626
52. Reznikoff CA, Bertram JS, Brankow DW, Heidelberger C (1973) Quantitative and qualitative studies of chemical transformation of cloned C3H mouse embryo cells sensitive to postconfluence inhibition of cell division. Cancer Res 33:3239-3249
53. Mitchel REJ, Jackson JS, McCann RA, Boreham DR (1999) The adaptive response modifies latency for radiation-induced myeloid leukemia in CBA/H mice. Radiat Res 152:273-279
54. Mitchel REJ, Dolling J-A, Misonoh J, Boreham DR (2002) Influence of prior exposure to low-dose adapting radiation on radiation-induced teratogenic effects in fetal mice with varying Trp53 function. Radiat Res 158:458-463
55. Mitchel REJ, Jackson JS, Morrison DP, Carlisle SM (2003) Low doses of radiation increase the latency of spontaneous lymphomas and spinal osteosarcomas in cancer-prone, radiation-sensitive Trp53 heterozygous mice. Radiat Res 159:320-327
56. Mitchel REJ, Jackson JS, Carlisle SM (2004) Upper dose thresholds for radiation-induced adaptive response against cancer in high-dose-exposed, cancer-prone, radiation-sensitive Trp53 heterozygous mice. Radiat Res 162:20-30
57. Mitchel REJ (2006) Low doses of radiation are protective in vitro and in vivo: evolutionary origins. Dose-Response 4:75-90
58. Mitchel REJ (2007) Low doses of radiation reduce risk in vivo. Dose-Response 5:1-10
59. Friedberg EC, Walker GC, Siede W, Wood RD, Schultz RA, Ellenberger T (2006) DNA repair and mutagenesis. ASM Press, Washington DC
60. Swift M, Sholman L, Perry M, Chase C (1976) Malignant neoplasms in the families of patients with ataxia-telangiectasia. Cancer Res 36:209-215
61. Inskip HM, Kinlen LJ, Taylor AMR, Woods CG, Arlett CF (1999) Risk of breast cancer and other cancers in heterozygotes for ataxia-telangiectasia. Br J Cancer 79:1304-1307
62. Swift M, Reitnauer PJ, Morrell D, Chase CL (1987) Breast and other cancers in families with ataxia-telangiectasia. N Engl J Med 316:1289-1294
63. Gatti RA, Tward A, Concannon P (1999) Cancer risk in ATM heterozygotes: a model of phenotypic and mechanistic differences between missense and truncating mutations. Mol Genet Metab 68:419-423
64. Bernstein JL, Langholz B, Haile RW, Bernstein L, Thomas DC, Stovall M, Malone KE, Lynch CF, Olsen JH, Anton-Culver H, Shore RE, Boice JD Jr, Berkowitz GS, Gatti RA, Teitelbaum SL, Smith SA, Rosenstein BS, Børresen-Dale A-L, Concannon P, Thompson WD (2004) Study design: Evaluating gene-environment interactions in the etiology of breast cancer - the WECARE study. Breast Cancer Res 6:R199-R214
65. Bernstein JL, Teraoka S, Haile RW, Børresen-Dale A-L, Rosenstein BS, Gatti RA, Diep AT, Jansen L, Atencio DP, Olsen JH, Bernstein L, Teitelbaum SL, Thompson WD, Concannon P, WECARE Study Collaborative Group (2003) Designing and implementing quality control for multi-center screening of mutations in the ATM gene among women with breast cancer. Hum Mutat 21:542-550
66. Conti DV, Cortessis V, Molitor J, Thomas DC (2003) Bayesian modeling of complex metabolic pathways. Hum Hered 56:83-93